CAMPTOTHECIN ANALOGUES/CISPLASTIN: AN EFFECTIVE TREATMENT OF ADVANCED BLADDER CANCER IN A PRECLINICAL IN VIVO MODEL SYSTEM
- 1 July 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (1) , 252-256
- https://doi.org/10.1016/s0022-5347(01)63099-4
Abstract
Conclusion The combination of CDDP with these camptothecin analogs is an effective therapy against this model of advanced TCC. These observations suggest potential clinical value.Keywords
This publication has 8 references indexed in Scilit:
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- The Therapeutic Impact of Dipyridamole: Chemopotentiation of the Cytotoxic Combination 5-Fluorouracil/Cisplatin in an Animal Model of Human Bladder CancerJournal of Urology, 1991
- The S-phase cytotoxicity of camptothecinExperimental Cell Research, 1991
- Dipyridamole-Cisplatin Potentiation: Enhanced in Vivo Cytotoxicity in Xenograft Models of Human Testicular and Bladder CancersJournal of Urology, 1990
- M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1988
- Predictive testing with the subrenal capsule assayCancer Treatment Reviews, 1984
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966